Hadjula, Nica T.
HRN: 24-47-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2024
02/02/2024
IV
465mg
Every 8 Hours
AGE With Mild Dehydration R/O Acute Appendicitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes